126 related articles for article (PubMed ID: 11844681)
41. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336.
Ganguly AK; Doll RJ; Girijavallabhan VM
Curr Med Chem; 2001 Oct; 8(12):1419-36. PubMed ID: 11562275
[TBL] [Abstract][Full Text] [Related]
42. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.
Houssin R; Pommery J; Salaün MC; Deweer S; Goossens JF; Chavatte P; Hénichart JP
J Med Chem; 2002 Jan; 45(2):533-6. PubMed ID: 11784157
[TBL] [Abstract][Full Text] [Related]
44. Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives.
Gwaltney SL; O'Connor SJ; Nelson LT; Sullivan GM; Imade H; Wang W; Hasvold L; Li Q; Cohen J; Gu WZ; Tahir SK; Bauch J; Marsh K; Ng SC; Frost DJ; Zhang H; Muchmore S; Jakob CG; Stoll V; Hutchins C; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2003 Apr; 13(7):1359-62. PubMed ID: 12657282
[TBL] [Abstract][Full Text] [Related]
45. [Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors].
Wan SB; Yi X; Guo ZR
Yao Xue Xue Bao; 2002 Apr; 37(4):257-62. PubMed ID: 12579819
[TBL] [Abstract][Full Text] [Related]
46. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors of farnesyl protein transferase.
Njoroge FG; Vibulbhan B; Wong JK; White SK; Wong SC; Carruthers NI; Kaminski JJ; Doll RJ; Girijavallabhan V; Ganguly AK
Org Lett; 1999 Nov; 1(9):1371-3. PubMed ID: 10825985
[TBL] [Abstract][Full Text] [Related]
48. Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.
Le Diguarher T; Ortuno JC; Dorey G; Shanks D; Guilbaud N; Pierré A; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
Bioorg Med Chem; 2003 Jul; 11(14):3193-204. PubMed ID: 12818682
[TBL] [Abstract][Full Text] [Related]
49. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
Mitsch A; Böhm M; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
[TBL] [Abstract][Full Text] [Related]
50. Mass spectrometric studies of potent inhibitors of farnesyl protein transferase--detection of pentameric noncovalent complexes.
Mirza UA; Chen G; Liu YH; Doll RJ; Girijavallabhan VM; Ganguly AK; Pramanik BN
J Mass Spectrom; 2008 Oct; 43(10):1393-401. PubMed ID: 18438977
[TBL] [Abstract][Full Text] [Related]
51. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
[TBL] [Abstract][Full Text] [Related]
52. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Lipari P; Malkowski M; Ferrari E; Nielsen L; Prioli N; Dell J; Sinha D; Syed J; Korfmacher WA; Nomeir AA; Lin CC; Wang L; Taveras AG; Doll RJ; Njoroge FG; Mallams AK; Remiszewski S; Catino JJ; Girijavallabhan VM; Bishop WR
Cancer Res; 1998 Nov; 58(21):4947-56. PubMed ID: 9810004
[TBL] [Abstract][Full Text] [Related]
53. Total synthesis of (±)-bisabosqual A.
am Ende CW; Zhou Z; Parker KA
J Am Chem Soc; 2013 Jan; 135(2):582-5. PubMed ID: 23268693
[TBL] [Abstract][Full Text] [Related]
54. Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis.
Singh SB; Zink DL; Williams M; Polishook JD; Sanchez M; Silverman KC; Lingham RB
Bioorg Med Chem Lett; 1998 Aug; 8(16):2071-6. PubMed ID: 9873488
[TBL] [Abstract][Full Text] [Related]
55. Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking.
Pedretti A; Villa L; Vistoli G
J Med Chem; 2002 Mar; 45(7):1460-5. PubMed ID: 11906287
[TBL] [Abstract][Full Text] [Related]
56. Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase.
Dinsmore CJ; Williams TM; O'Neill TJ; Liu D; Rands E; Culberson JC; Lobell RB; Koblan KS; Kohl NE; Gibbs JB; Oliff AI; Graham SL; Hartman GD
Bioorg Med Chem Lett; 1999 Dec; 9(23):3301-6. PubMed ID: 10612589
[TBL] [Abstract][Full Text] [Related]
57. Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Zheng X; Baumeister T; Buckmelter AJ; Caligiuri M; Clodfelter KH; Han B; Ho YC; Kley N; Lin J; Reynolds DJ; Sharma G; Smith CC; Wang Z; Dragovich PS; Oh A; Wang W; Zak M; Wang Y; Yuen PW; Bair KW
Bioorg Med Chem Lett; 2014 Jan; 24(1):337-43. PubMed ID: 24279990
[TBL] [Abstract][Full Text] [Related]
58. A novel route to preussomerins via 2-arylacetal anions.
Ragot JP; Prime ME; Archibald SJ; Taylor RJ
Org Lett; 2000 Jun; 2(11):1613-6. PubMed ID: 10841492
[TBL] [Abstract][Full Text] [Related]
59. Hydroxamic acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.
Patel DV; Young MG; Robinson SP; Hunihan L; Dean BJ; Gordon EM
J Med Chem; 1996 Oct; 39(21):4197-210. PubMed ID: 8863797
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice.
Zhang L; Chen J; Ning M; Zou Q; Leng Y; Shen J
Bioorg Med Chem Lett; 2012 Apr; 22(8):2748-52. PubMed ID: 22440625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
